These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32371266)

  • 1. Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer.
    Monteiro PF; Gulfam M; Monteiro CJ; Travanut A; Abelha TF; Pearce AK; Jerôme C; Grabowska AM; Clarke PA; Collins HM; Heery DM; Gershkovich P; Alexander C
    J Control Release; 2020 Jul; 323():549-564. PubMed ID: 32371266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
    Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
    Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.
    Khurana RK; Kumar R; Gaspar BL; Welsby G; Welsby P; Kesharwani P; Katare OP; Singh KK; Singh B
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():645-658. PubMed ID: 30033299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
    Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T
    Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer.
    Paulmurugan R; Bhethanabotla R; Mishra K; Devulapally R; Foygel K; Sekar TV; Ananta JS; Massoud TF; Joy A
    Mol Cancer Ther; 2016 Feb; 15(2):221-31. PubMed ID: 26553061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
    Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
    Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed Co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment.
    Wang Y; Cheng W; Zhu J; He L; Ren W; Bao D; Piao JG
    Biomed Pharmacother; 2024 Jan; 170():116084. PubMed ID: 38157645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LHRH-Targeted Redox-Responsive Crosslinked Micelles Impart Selective Drug Delivery and Effective Chemotherapy in Triple-Negative Breast Cancer.
    Xiao K; Liu Q; Suby N; Xiao W; Agrawal R; Vu M; Zhang H; Luo Y; Li Y; Lam KS
    Adv Healthc Mater; 2021 Feb; 10(3):e2001196. PubMed ID: 33200571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
    Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
    J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
    Kutty RV; Feng SS
    Biomaterials; 2013 Dec; 34(38):10160-71. PubMed ID: 24090836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
    Doddapaneni R; Patel K; Chowdhury N; Singh M
    Exp Cell Res; 2016 Aug; 346(1):65-73. PubMed ID: 27177833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
    Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
    Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment.
    Gong C; Hu C; Gu F; Xia Q; Yao C; Zhang L; Qiang L; Gao S; Gao Y
    J Control Release; 2017 Nov; 266():272-286. PubMed ID: 28987884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles.
    Chen R; Ni S; Chen W; Liu M; Feng J; Hu K
    Int J Nanomedicine; 2021; 16():5265-5279. PubMed ID: 34376979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction-responsive core-crosslinked hyaluronic acid-b-poly(trimethylene carbonate-co-dithiolane trimethylene carbonate) micelles: synthesis and CD44-mediated potent delivery of docetaxel to triple negative breast tumor in vivo.
    Zhu Y; Zhang J; Meng F; Cheng L; Feijen J; Zhong Z
    J Mater Chem B; 2018 May; 6(19):3040-3047. PubMed ID: 32254339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.